Cargando…
When it just won’t go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress
BACKGROUND: Oral artemisinin monotherapy (AMT), an important contributor to multi-drug resistant malaria, has been banned in Nigeria. While oral AMT has scarcely been found for several years now in other malaria-endemic countries, availability has persisted in Nigeria’s private sector. In 2015, the...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732368/ https://www.ncbi.nlm.nih.gov/pubmed/29246208 http://dx.doi.org/10.1186/s12936-017-2102-7 |